NO20033964L - Anvendelse av tiolutindioksid og dets derivater ved fremstilling av et legemiddel, og en fremgangsmåte for fremstillingen derav - Google Patents

Anvendelse av tiolutindioksid og dets derivater ved fremstilling av et legemiddel, og en fremgangsmåte for fremstillingen derav

Info

Publication number
NO20033964L
NO20033964L NO20033964A NO20033964A NO20033964L NO 20033964 L NO20033964 L NO 20033964L NO 20033964 A NO20033964 A NO 20033964A NO 20033964 A NO20033964 A NO 20033964A NO 20033964 L NO20033964 L NO 20033964L
Authority
NO
Norway
Prior art keywords
medicament
derivatives
manufacture
dioxide
thiolutine
Prior art date
Application number
NO20033964A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033964D0 (no
Inventor
Claudia Eder
Michael Kurz
Joachim Wink
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20033964D0 publication Critical patent/NO20033964D0/no
Publication of NO20033964L publication Critical patent/NO20033964L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20033964A 2001-03-09 2003-09-08 Anvendelse av tiolutindioksid og dets derivater ved fremstilling av et legemiddel, og en fremgangsmåte for fremstillingen derav NO20033964L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01105959A EP1238668A1 (en) 2001-03-09 2001-03-09 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof
PCT/EP2002/001915 WO2002072089A2 (en) 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
NO20033964D0 NO20033964D0 (no) 2003-09-08
NO20033964L true NO20033964L (no) 2003-09-08

Family

ID=8176735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033964A NO20033964L (no) 2001-03-09 2003-09-08 Anvendelse av tiolutindioksid og dets derivater ved fremstilling av et legemiddel, og en fremgangsmåte for fremstillingen derav

Country Status (24)

Country Link
US (2) US20020193418A1 (cs)
EP (2) EP1238668A1 (cs)
JP (1) JP2004521927A (cs)
KR (1) KR20040025902A (cs)
CN (1) CN1279906C (cs)
AT (1) ATE333276T1 (cs)
AU (1) AU2002250997B2 (cs)
BG (1) BG108161A (cs)
BR (1) BR0207884A (cs)
CA (1) CA2439853A1 (cs)
CZ (1) CZ20032427A3 (cs)
DE (1) DE60213219D1 (cs)
EE (1) EE200300430A (cs)
HR (1) HRP20030714A2 (cs)
IL (1) IL157792A0 (cs)
MX (1) MXPA03007551A (cs)
NO (1) NO20033964L (cs)
NZ (1) NZ528071A (cs)
PL (1) PL363374A1 (cs)
RU (1) RU2003129889A (cs)
SK (1) SK11202003A3 (cs)
WO (1) WO2002072089A2 (cs)
YU (1) YU68403A (cs)
ZA (1) ZA200306474B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108371661B (zh) * 2018-01-19 2019-03-19 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用
CN113209088B (zh) * 2021-03-11 2022-03-22 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用
CN115261422B (zh) * 2022-06-30 2024-07-16 塔里木大学 一种新物种来源硫藤黄菌素的制备方法及应用
CN118477070B (zh) * 2024-05-15 2025-09-09 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在预防和/或治疗放射性肺损伤中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217957A1 (en) * 1995-04-11 1996-10-17 Genhui Chen Xenorxides with antibacterial and antimycotic properties
CA2212237A1 (en) * 1997-09-05 1999-03-05 John M. Webster Novel antineoplastic agents

Also Published As

Publication number Publication date
CA2439853A1 (en) 2002-09-19
NO20033964D0 (no) 2003-09-08
EP1238668A1 (en) 2002-09-11
EP1372640A2 (en) 2004-01-02
IL157792A0 (en) 2004-03-28
JP2004521927A (ja) 2004-07-22
RU2003129889A (ru) 2005-03-10
EE200300430A (et) 2003-12-15
PL363374A1 (en) 2004-11-15
KR20040025902A (ko) 2004-03-26
AU2002250997B2 (en) 2006-03-09
SK11202003A3 (sk) 2004-02-03
BR0207884A (pt) 2004-07-27
ZA200306474B (en) 2004-04-29
WO2002072089A2 (en) 2002-09-19
YU68403A (sh) 2006-08-17
ATE333276T1 (de) 2006-08-15
CZ20032427A3 (cs) 2004-01-14
DE60213219D1 (de) 2006-08-31
CN1501800A (zh) 2004-06-02
HRP20030714A2 (en) 2005-04-30
BG108161A (en) 2004-09-30
US20020193418A1 (en) 2002-12-19
CN1279906C (zh) 2006-10-18
US20050059725A1 (en) 2005-03-17
NZ528071A (en) 2005-02-25
MXPA03007551A (es) 2003-12-04
WO2002072089A3 (en) 2002-11-14
EP1372640B1 (en) 2006-07-19

Similar Documents

Publication Publication Date Title
NO20024772L (no) Percyquinnin, fremgangsmÕte for dets fremstilling og dets anvendelse som et legemiddel
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
BR0015533A (pt) Iduronidase-alfa-l recombinante, métodos para sua produção e purificação e métodos para tratamento de doenças causadas por deficiências da mesma
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
TNSN04082A1 (en) N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
MXPA04002405A (es) Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
NO20032111L (no) Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
WO2003078430A8 (de) Essig- und propionsäureamide
WO2002076438A3 (en) Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
MY139368A (en) Novel cyclohexyl sulphones
NO20033964D0 (no) Anvendelse av tiolutindioksid og dets derivater ved fremstilling av et legemiddel, og en fremgangsmåte for fremstillingen derav
ATE334124T1 (de) Chinolinderivate, herstellungsprozess und verwendung zur behandlung von krankheiten, bei den s-cd23 involviert ist
MXPA03010205A (es) Derivados de acido oxalico.
BRPI0415529A (pt) derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas
MXPA03002047A (es) Fenilciclohexanocarboxamidas substituidas y su uso.
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
MXPA04001951A (es) Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos.
BR0312337A (pt) Derivados de ácido polienocarboxìlico, processo para a sua preparação e seu emprego
ATE354639T1 (de) Virulenz gene, proteine, und ihre verwendung
DE50102262D1 (de) Verwendung von 2-methyl-thiazolidin 2,4-dicarbonsäure zur herstellung eines medikaments zur behandlung von infektionskrankheiten
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.